PATENT CLAIM ANALYSIS

Application Number: 15861017
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["514", "259000"]

Abstract:
A method of treating a pediatric cancer in a subject in need thereof. The method includes administering to the subject a therapeutically effective amount of (S)—N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide, or a pharmaceutically acceptable salt thereof, or a combination thereof.

Claim (Index 26):
The method of  claim 25 , wherein the dysregulation of a NTRK gene, a Trk protein, or expression or level of the same is a chromosome translation that results in the translation of a Trk fusion protein.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 86.0
- Lexical Diversity: 1.5122
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15622388', '15622544', '15399207', '15706062', '15785228']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8148467770509739
- 35 USC 102 Novelty (BERT): 0.6207178346582027
- Combined Prediction Score: 0.7954338828116968
- Mean Citation Score: 432.988974
- Max Citation Score: 603.2879
- Similarity Product: 483.67730247635245

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test